BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 10430092)

  • 41. [Alterations of locus P16INK4a/P14ARF in non-small cell lung cancer].
    Skrzypski M; Jassem E; Jassem J
    Pneumonol Alergol Pol; 2003; 71(9-10):471-8. PubMed ID: 15052984
    [No Abstract]   [Full Text] [Related]  

  • 42. p16INK4a: a gene with a dual capacity to encode unrelated proteins that inhibit cell cycle progression.
    Larsen CJ
    Oncogene; 1996 May; 12(10):2041-4. PubMed ID: 8668328
    [No Abstract]   [Full Text] [Related]  

  • 43. Molecular genetic parameters in pathogenesis and prognosis of testicular germ cell tumors.
    Heidenreich A; Srivastava S; Moul JW; Hofmann R
    Eur Urol; 2000 Feb; 37(2):121-35. PubMed ID: 10705188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis.
    Wagner KD; Wagner N
    Cells; 2022 Jun; 11(12):. PubMed ID: 35741095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two tracks but one race? Cancer genetics.
    Sidransky D
    Curr Biol; 1996 May; 6(5):523-5. PubMed ID: 8805269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Splicing into senescence: the curious case of p16 and p19ARF.
    Haber DA
    Cell; 1997 Nov; 91(5):555-8. PubMed ID: 9393847
    [No Abstract]   [Full Text] [Related]  

  • 47. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
    Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M
    Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Inhibitors of cyclins/CDK of the 9p21 chromosomal region and malignant hemopathies].
    Quesnel B
    Bull Cancer; 1998 Sep; 85(9):747-54. PubMed ID: 9817058
    [TBL] [Abstract][Full Text] [Related]  

  • 49. p16ink4a gene and hematological malignancies.
    Quesnel B; Preudhomme C; Fenaux P
    Leuk Lymphoma; 1996 Jun; 22(1-2):11-24. PubMed ID: 8724524
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Tribulations of the p16/MTS1/CDKN2 tumor gene suppressor: a continuing saga].
    Larsen CJ
    Bull Cancer; 1997 Apr; 84(4):427-30. PubMed ID: 9238169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
    Drexler HG
    Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 3.